 BERKELEY, Calif. and MAINZ, Germany, Jan. 11, 2022 GLOBE NEWSWIRE -- Mainz Biomed N.V. NASDAQ:MYNZ Mainz Biomed or the Company, a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that Guido Baechler, Chief Executive Officer, will present at the H.C. Wainwright Bioconnect Virtual Conference taking place on January 10-13, 2022. 